- Directors’ / PDMR Dealing and Grant of Options
- Results for the Year ended 31 December 2023
- Notice of Results and Investor Presentation
- Eroxon to be available on prescription
- Trading Update
- Appointment of Joint Corporate Broker
- Director/PDMR Dealing
- Remuneration of Non-Exec Directors & Voting Rights
- Futura Medical extends collaboration with Cooper
- Appointment of Roy Davis as Non-Executive Director
More ▼
Key statistics
On Wednesday, Futura Medical PLC (FUM:LSE) closed at 39.25, 68.59% above the 52 week low of 23.28 set on Dec 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.70 |
---|---|
High | 39.75 |
Low | 38.70 |
Bid | 38.75 |
Offer | 60.00 |
Previous close | 39.25 |
Average volume | 272.93k |
---|---|
Shares outstanding | 301.45m |
Free float | 199.72m |
P/E (TTM) | -- |
Market cap | 116.43m GBP |
EPS (TTM) | -0.0219 GBP |
Data delayed at least 20 minutes, as of May 22 2024 16:35 BST.
More ▼